返回
S
Sanjay Popat
the royal marsden hospital - nhs foundation trust
65H指数
803论文数
3.0W被引数
收录论文 234
发表时间
Ivonescimab plus chemotherapy versus placebo plus chemotherapy in patients with advanced EGFR-mutated non-small-cell lung cancer after disease progression on EGFR tyrosine kinase inhibitor therapy (HARMONi): a multicentre, randomised, double-blind, phase 3 trial伊沃奈司单抗联合化疗与安慰剂联合化疗在EGFR突变型晚期非小细胞肺癌患者中的疗效比较(患者既往接受EGFR酪氨酸激酶抑制剂治疗后疾病进展)(HARMONi研究):一项多中心、随机、双盲、Ⅲ期临床试验
Lancet Oncology
IF35.9

